BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 32710569)

  • 21. Extensive biliary intraepithelial neoplasia (BilIN) and multifocal early intrahepatic cholangiocarcinoma in non-biliary cirrhosis.
    Rougemont AL; Genevay M; McKee TA; Gremaud M; Mentha G; Rubbia-Brandt L
    Virchows Arch; 2010 Jun; 456(6):711-7. PubMed ID: 20428886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-145 functions as a tumor suppressor targeting NUAK1 in human intrahepatic cholangiocarcinoma.
    Xiong X; Sun D; Chai H; Shan W; Yu Y; Pu L; Cheng F
    Biochem Biophys Res Commun; 2015 Sep; 465(2):262-9. PubMed ID: 26255969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells.
    Utaijaratrasmi P; Vaeteewoottacharn K; Tsunematsu T; Jamjantra P; Wongkham S; Pairojkul C; Khuntikeo N; Ishimaru N; Sirivatanauksorn Y; Pongpaibul A; Thuwajit P; Thuwajit C; Kudo Y
    Mol Cancer; 2018 Jan; 17(1):10. PubMed ID: 29347950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z; Ma J
    Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-199a-3p enhances cisplatin sensitivity of cholangiocarcinoma cells by inhibiting mTOR signaling pathway and expression of MDR1.
    Li Q; Xia X; Ji J; Ma J; Tao L; Mo L; Chen W
    Oncotarget; 2017 May; 8(20):33621-33630. PubMed ID: 28422725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CpG island hypermethylation and repetitive DNA hypomethylation in premalignant lesion of extrahepatic cholangiocarcinoma.
    Kim BH; Cho NY; Shin SH; Kwon HJ; Jang JJ; Kang GH
    Virchows Arch; 2009 Oct; 455(4):343-51. PubMed ID: 19763613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway.
    Leng K; Xu Y; Kang P; Qin W; Cai H; Wang H; Ji D; Jiang X; Li J; Li Z; Huang L; Zhong X; Sun X; Wang Z; Cui Y
    Cell Death Dis; 2019 Mar; 10(4):262. PubMed ID: 30886152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma.
    Matsushima H; Kuroki T; Kitasato A; Adachi T; Tanaka T; Hirabaru M; Hirayama T; Kuroshima N; Hidaka M; Soyama A; Takatsuki M; Kinoshita N; Sano K; Nishida N; Eguchi S
    Dig Liver Dis; 2015 Dec; 47(12):1067-75. PubMed ID: 26341967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Over-expression of polycomb group protein EZH2 relates to decreased expression of p16 INK4a in cholangiocarcinogenesis in hepatolithiasis.
    Sasaki M; Yamaguchi J; Itatsu K; Ikeda H; Nakanuma Y
    J Pathol; 2008 Jun; 215(2):175-83. PubMed ID: 18393368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma.
    Li H; Zhou ZQ; Yang ZR; Tong DN; Guan J; Shi BJ; Nie J; Ding XT; Li B; Zhou GW; Zhang ZY
    Hepatology; 2017 Jul; 66(1):136-151. PubMed ID: 28194813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different carcinogenic process in cholangiocarcinoma cases epidemically developing among workers of a printing company in Japan.
    Sato Y; Kubo S; Takemura S; Sugawara Y; Tanaka S; Fujikawa M; Arimoto A; Harada K; Sasaki M; Nakanuma Y
    Int J Clin Exp Pathol; 2014; 7(8):4745-54. PubMed ID: 25197345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Let-7c inhibits cholangiocarcinoma growth but promotes tumor cell invasion and growth at extrahepatic sites.
    Xie Y; Zhang H; Guo XJ; Feng YC; He RZ; Li X; Yu S; Zhao Y; Shen M; Zhu F; Wang X; Wang M; Balakrishnan A; Ott M; Peng F; Qin RY
    Cell Death Dis; 2018 Feb; 9(2):249. PubMed ID: 29445149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma.
    McNally ME; Collins A; Wojcik SE; Liu J; Henry JC; Jiang J; Schmittgen T; Bloomston M
    HPB (Oxford); 2013 Apr; 15(4):260-4. PubMed ID: 23458262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA profiling of human intrahepatic cholangiocarcinoma cell lines reveals biliary epithelial cell-specific microRNAs.
    Kawahigashi Y; Mishima T; Mizuguchi Y; Arima Y; Yokomuro S; Kanda T; Ishibashi O; Yoshida H; Tajiri T; Takizawa T
    J Nippon Med Sch; 2009 Aug; 76(4):188-97. PubMed ID: 19755794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis.
    Itatsu K; Zen Y; Ohira S; Ishikawa A; Sato Y; Harada K; Ikeda H; Sasaki M; Nimura Y; Nakanuma Y
    Liver Int; 2007 Nov; 27(9):1174-84. PubMed ID: 17919228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-376c down-regulation accelerates EGF-dependent migration by targeting GRB2 in the HuCCT1 human intrahepatic cholangiocarcinoma cell line.
    Iwaki J; Kikuchi K; Mizuguchi Y; Kawahigashi Y; Yoshida H; Uchida E; Takizawa T
    PLoS One; 2013; 8(7):e69496. PubMed ID: 23922722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DMBT1 expression in biliary carcinogenesis with correlation of clinicopathological data.
    Goeppert B; Roessler S; Becker N; Zucknick M; Vogel MN; Warth A; Pathil-Warth A; Mehrabi A; Schirmacher P; Mollenhauer J; Renner M
    Histopathology; 2017 Jun; 70(7):1064-1071. PubMed ID: 28130841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepatolithiasis.
    Zen Y; Sasaki M; Fujii T; Chen TC; Chen MF; Yeh TS; Jan YY; Huang SF; Nimura Y; Nakanuma Y
    J Hepatol; 2006 Feb; 44(2):350-8. PubMed ID: 16360234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
    Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W
    Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Mir-122 on Human Cholangiocarcinoma Proliferation, Invasion, and Apoptosis Through P53 Expression.
    Wu C; Zhang J; Cao X; Yang Q; Xia D
    Med Sci Monit; 2016 Jul; 22():2685-90. PubMed ID: 27472451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.